Topical copper peptides primarily affect the epidermis and upper dermis, where penetration allows direct delivery
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Results were reportedly submitted to ClinicalTrials.gov on May 23, 2016, but the study itself is listed as canceled, which indicates the study sponsor or investigator recalled a submission of study results before quality control review took place
These observations align with improved peripheral blood flow from nitric oxide-mediated vasodilation, though they could also reflect placebo effects or confirmation bias
Peptides are short chains of amino acids that act as signaling molecules within the body, influencing processes such as healing, inflammation, immune response, and cellular repair
Access our weekly newsletter